DEA Reschedules Hydrocodone Combination Products

Posted in Latest News on September 9, 2014.

On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.

The entire rule text may be found here: https://www.federalregister.gov/articles/2014/08/22/2014-19922/schedules-of-controlled-substances-rescheduling-of-hydrocodone-combination-products-from-schedule



More Latest News

Board Chairs, Vice Chairs & Associations’ Meeting Announcement
September 9, 2016

The Florida Department of Health, Division of Medical Quality Assurance (MQA) announces the following meetings: Continue reading


Telehealth Survey
August 10, 2016

Let your voice be heard about telehealth practices in Florida. The Telehealth Survey lets health care practitioners provide valuable information to Florida lawmakers. Continue reading